EMBC Stock Overview
A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Embecta Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$14.82 |
| 52 Week High | US$20.70 |
| 52 Week Low | US$9.93 |
| Beta | 0.95 |
| 11 Month Change | 12.53% |
| 3 Month Change | 7.78% |
| 1 Year Change | -24.70% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Recent News & Updates
Embecta Corp. Just Beat EPS By 79%: Here's What Analysts Think Will Happen Next
Aug 14
When Should You Buy Embecta Corp. (NASDAQ:EMBC)?
Jul 13Recent updates
Embecta Corp. Just Beat EPS By 79%: Here's What Analysts Think Will Happen Next
Aug 14When Should You Buy Embecta Corp. (NASDAQ:EMBC)?
Jul 13Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 12Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15
Feb 21Embecta Corp.'s (NASDAQ:EMBC) Prospects Need A Boost To Lift Shares
Jul 16Embecta Corp. (NASDAQ:EMBC) Shares Could Be 37% Below Their Intrinsic Value Estimate
Mar 30Embecta Corp. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 17Embecta: Comments On 2nd Earnings Since Spin Off
Sep 04Some Investors May Be Willing To Look Past Embecta's (NASDAQ:EMBC) Soft Earnings
Aug 23Embecta GAAP EPS of $1.07 beats by $0.20, revenue of $291.1M beats by $14.24M
Aug 15Embecta Is A Winner In A Growing Market
Jun 07Embecta: Not Love At First Sight
Apr 04Shareholder Returns
| EMBC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 3.1% | 1.6% | 3.6% |
| 1Y | -24.7% | 4.5% | 20.3% |
Return vs Industry: EMBC underperformed the US Medical Equipment industry which returned 3.1% over the past year.
Return vs Market: EMBC underperformed the US Market which returned 16.9% over the past year.
Price Volatility
| EMBC volatility | |
|---|---|
| EMBC Average Weekly Movement | 7.7% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: EMBC's share price has been volatile over the past 3 months.
Volatility Over Time: EMBC's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1924 | 2,200 | Dev Kurdikar | www.embecta.com |
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally.
Embecta Corp. Fundamentals Summary
| EMBC fundamental statistics | |
|---|---|
| Market cap | US$851.10m |
| Earnings (TTM) | US$69.70m |
| Revenue (TTM) | US$1.12b |
12.3x
P/E Ratio0.8x
P/S RatioIs EMBC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMBC income statement (TTM) | |
|---|---|
| Revenue | US$1.12b |
| Cost of Revenue | US$375.70m |
| Gross Profit | US$743.20m |
| Other Expenses | US$673.50m |
| Earnings | US$69.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.21 |
| Gross Margin | 66.42% |
| Net Profit Margin | 6.23% |
| Debt/Equity Ratio | -209.5% |
How did EMBC perform over the long term?
See historical performance and comparison